🇺🇸 FDA
Patent

US 10258701

Labeled evans blue dye derivative for in vivo serum albumin labeling

granted A61KA61K51/0482

Quick answer

US patent 10258701 (Labeled evans blue dye derivative for in vivo serum albumin labeling) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Apr 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K51/0482